Crossject Société Anonyme
EPA:ALCJ.PA
Overview | Financials
Company Name | Crossject Société Anonyme |
Symbol | ALCJ.PA |
Currency | EUR |
Price | 2.375 |
Market Cap | 97,732,027 |
Dividend Yield | 0% |
52-week-range | 1.52 - 5.96 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Patrick Alexandre |
Website | https://www.crossject.com |
An error occurred while fetching data.
About Crossject Société Anonyme
Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD